首页> 美国卫生研究院文献>World Journal of Gastroenterology >Low-volume plus ascorbic acid vs high-volume plus simethicone bowel preparation before colonoscopy
【2h】

Low-volume plus ascorbic acid vs high-volume plus simethicone bowel preparation before colonoscopy

机译:结肠镜检查前小剂量加抗坏血酸与大剂量加二甲硅油肠道准备

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate the effectiveness of low-volume plus ascorbic acid [polyethylene glycol plus ascorbic acid (PEG + Asc)] and high-volume plus simethicone [polyethylene glycol plus simethicone (PEG + Sim)] bowel preparations.METHODS: A total of one hundred and forty-four outpatients (76 males), aged from 20 to 84 years (median age 59.5 years), who attended our Department, were divided into two groups, age and sex matched, and underwent colonoscopy. Two questionnaires, one for patients reporting acceptability and the other for endoscopists evaluating bowel cleansing effectiveness according to validated scales, were completed. Indications, timing of examination and endoscopical findings were recorded. Biopsy forceps were used as a measuring tool in order to determine polyp endoscopic size estimation. Difficulty in completing the preparation was rated in a 5-point Likert scale (1 = easy to 5 = unable). Adverse experiences (fullness, cramps, nausea, vomiting, abdominal pain, headache and insomnia), number of evacuations and types of activities performed during preparation (walking or resting in bed) were also investigated.RESULTS: Seventy-two patients were selected for each group. The two groups were age and sex matched as well as being comparable in terms of medical history and drug therapies taken. Fourteen patients dropped out from the trial because they did not complete the preparation procedure. Ratings of global bowel cleansing examinations were considered to be adequate in 91% of PEG + Asc and 88% of PEG + Sim patients. Residual Stool Score indicated similar levels of amount and consistency of residual stool; there was a significant difference in the percentage of bowel wall visualization in favour of PEG + Sim patients. In the PEG + Sim group, 12 adenomas ≤ 10 mm diameter (5/left colon + 7/right colon) vs 9 (8/left colon + 1/right colon) in the PEG + Asc group were diagnosed. Visualization of small lesions seems to be one of the primary advantages of the PEG + Sim preparation.CONCLUSION: PEG + Asc is a good alternative solution as a bowel preparation but more improvements are necessary in order to achieve the target of a perfect preparation.
机译:目的:研究小剂量加抗坏血酸[聚乙二醇加抗坏血酸(PEG + Asc)]和大剂量加西甲硅油[聚乙二醇加二甲硅油(PEG + Sim)]肠道制剂的有效性。方法:共计进入我科的一百四十四名门诊患者(76名男性)年龄在20至84岁(中位年龄59.5岁),分为年龄和性别相匹配的两组,并接受了结肠镜检查。已完成两份调查表,一份用于报告可接受性的患者,另一份用于根据验证的量表评估肠清洁效果的内镜医师。记录适应症,检查时间和内窥镜检查结果。活检钳用作测量工具,以确定息肉内窥镜大小估计。完成准备的难度以5分李克特量表(1 =容易5 =无法)进行评分。还调查了不良经历(饱胀,抽筋,恶心,呕吐,腹痛,头痛和失眠),疏散次数和准备过程中进行的活动类型(行走或躺在床上)。结果:每例选择72例患者。组。两组的年龄和性别相匹配,并且在病史和药物治疗方面具有可比性。 14名患者因为未完成准备程序而退出试验。在91%的PEG + Asc和88%的PEG + Sim患者中,全球肠道清洁检查的评分被认为是足够的。残余粪便评分表明残余粪便的数量和浓度水平相近;对于PEG + Sim患者,肠壁可视化百分比存在显着差异。在PEG + Sim组中,诊断出直径≤10 mm的12个腺瘤(5个/左结肠+ 7个/右结肠)与PEG + Asc组的9个腺瘤(8个/左结肠+ 1 /右结肠)相比。小病变的可视化似乎是PEG + Sim制剂的主要优势之一。结论:PEG + Asc是肠制剂的一种很好的替代解决方案,但要实现完美制剂的目标还需要进行更多改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号